Max Petersson

Director de Operaciones en Accuro Immunology AB .

Health Technology

Consumer Services

Perfil

Max Petersson is Chief Operating Officer of Accuro Immunology AB.
He was a Researcher and an Assistant Professor of Karolinska Institute.
He received a PhD from Karolinska Institute.

Cargos activos de Max Petersson

Empresas	Cargo	Inicio
Accuro Immunology AB Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden.	Director de Operaciones	-

Todos los cargos activos de Max Petersson

Antiguos cargos conocidos de Max Petersson.

Empresas	Cargo	Fin
AngioGenetics AB AngioGenetics AB Pharmaceuticals: GenericHealth Technology AngioGenetics AB develops, markets, and distributes generic drugs. It develops angiogenesis modulating drugs for the treatment of cancer, ischemic heart disease, and eye diseases. The company was founded in June 2001 and is headquartered in Göteborg, Sweden.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Max Petersson.

Formación de Max Petersson.

Karolinska Institutet

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Max Petersson.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Accuro Immunology AB Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden.	Health Technology
AngioGenetics AB AngioGenetics AB Pharmaceuticals: GenericHealth Technology AngioGenetics AB develops, markets, and distributes generic drugs. It develops angiogenesis modulating drugs for the treatment of cancer, ischemic heart disease, and eye diseases. The company was founded in June 2001 and is headquartered in Göteborg, Sweden.	Health Technology

Ver las conexiones de la empresa